EUVIMEDEUVIMED entdecken
Crossref

LaCl3-Enabled Synthesis of 2′- C -Substituted Galidesivir Analogues

James M Wood iD, Rinu Shrestha, Ashley Nutsford, Blake Sullivan-Hill, Scott A Cameron iD, Hong Wang, Gary B Evans, Justin Julander, Natalie E Netzler iD, Lawrence D Harris iD

Organic Letters · 30.10.2026 · 28 (43) · 13493-13498

DOI: 10.1021/acs.orglett.6c03942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic Letters, online erschienen am 21.10.2026. Verfasst von James M Wood und 9 weiteren Autor:innen. Beteiligte Einrichtung: Ferrier Research Institute, Te Herenga Waka─Victoria University of Wellington, Wellington6012, New Zealand. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Division of Microbiology and Infectious Diseases, Ministry of Business, Innovation and Employment.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The first synthesis of 2′-C-ethynylgalidesivir is reported. Access to this highly congested imino-C-nucleoside required development of a LaCl3·2LiCl-enabled addition of a 9-deazaadenine-derived Grignard reagent to 2′-C-substituted cyclic nitrones. The reaction proceeds with high β selectivity and enables the synthesis of galidesivir, 2′-C-methylgalidesivir, and 2′-C-ethynylgalidesivir. The respective syntheses required 6, 11, and 11 steps from known intermediates and proceeded in 54%, 22% and 17% overall yield. NMR titration and order-of-addition studies suggested that LaCl3·2LiCl perturbs both the nitrone substrate and Grignard speciation. Antiviral evaluation of the ethynyl analogue and its phosphoramidate prodrug revealed only weak activity at high concentration.

Autor:innen und Institutionen

  • Ferrier Research Institute, Te Herenga Waka─Victoria University of Wellington, Wellington6012, New Zealand.
  • The Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland1010, New Zealand.
  • Department of Molecular Medicine and Pathology, School of Medical and Health Sciences, The University of Auckland, Auckland1023, New Zealand.
  • Institute for Antiviral Research, Utah State University, Logan, Utah84322-5600, United States.

ORCID-Profile: James M Wood, Scott A Cameron, Natalie E Netzler, Lawrence D Harris

Förderung

  • Division of Microbiology and Infectious Diseases
  • Ministry of Business, Innovation and Employment

Zitieren

APA

Wood, J. M., Shrestha, R., Nutsford, A., Sullivan-Hill, B., Cameron, S. A., Wang, H., Evans, G. B., Julander, J., Netzler, N. E., & Harris, L. D. (2026). LaCl3-Enabled Synthesis of 2′- C -Substituted Galidesivir Analogues. Organic Letters, 28(43), 13493-13498. https://doi.org/10.1021/acs.orglett.6c03942

Vancouver

Wood JM, Shrestha R, Nutsford A, Sullivan-Hill B, Cameron SA, Wang H, et al. LaCl3-Enabled Synthesis of 2′- C -Substituted Galidesivir Analogues. Organic Letters. 2026;28(43):13493-13498. doi:10.1021/acs.orglett.6c03942

BibTeX
@article{Wood2026,
  author = {Wood, James M and Shrestha, Rinu and Nutsford, Ashley and Sullivan-Hill, Blake and Cameron, Scott A and Wang, Hong and Evans, Gary B and Julander, Justin and Netzler, Natalie E and Harris, Lawrence D},
  title = {LaCl3-Enabled Synthesis of 2′- C -Substituted Galidesivir Analogues},
  journal = {Organic Letters},
  year = {2026},
  volume = {28},
  number = {43},
  pages = {13493--13498},
  doi = {10.1021/acs.orglett.6c03942}
}
Kostenlos starten →